KindlyMD (NASDAQ:NAKA) Issues Earnings Results, Beats Expectations By $4.56 EPS

KindlyMD (NASDAQ:NAKA) announced its quarterly earnings results on Friday. The company reported $4.07 EPS for the quarter, topping the consensus estimate of ($0.49) by $4.56, FiscalAI reports. The business had revenue of ($1.93) million for the quarter. KindlyMD had a negative return on equity of 71.15% and a negative net margin of 1,067.93%.

KindlyMD Stock Down 13.6%

Shares of NASDAQ NAKA traded down $0.79 during trading on Friday, hitting $5.00. 250,561 shares of the company traded hands, compared to its average volume of 171,962. The firm has a market capitalization of $91.75 million, a P/E ratio of -0.33 and a beta of 16.03. The company has a 50-day moving average price of $7.87 and a 200-day moving average price of $7.52. KindlyMD has a 1 year low of $3.33 and a 1 year high of $25.22.

Analysts Set New Price Targets

NAKA has been the subject of several recent research reports. Wall Street Zen raised KindlyMD from a “sell” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reissued a “sell (d-)” rating on shares of KindlyMD in a research note on Wednesday, November 4th. TD Cowen increased their target price on KindlyMD from $1.00 to $17.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Finally, B. Riley Financial lifted their price target on KindlyMD from $11.00 to $13.00 and gave the company a “buy” rating in a report on Tuesday, September 22nd. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $20.00.

Insider Buying and Selling at KindlyMD

In other news, CEO David F. Bailey bought 32,134 shares of KindlyMD stock in a transaction that occurred on Wednesday, August 19th. The shares were purchased at an average price of $5.59 per share, for a total transaction of $179,629.06. Following the completion of the acquisition, the chief executive officer owned 32,134 shares of the company’s stock, valued at $179,629.06. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Over the last 90 days, insiders acquired 41,904 shares of company stock valued at $235,231. Company insiders own 24.08% of the company’s stock.

About KindlyMD

KindlyMD is a Utah-based healthcare company that provides outpatient medical services, with a focus on integrated care. Its offerings include primary care, behavioral health and treatment for substance use disorders, along with care coordination intended to connect patients with appropriate services. The company serves patients through clinics in Utah and has emphasized care for people with complex or ongoing health needs. KindlyMD combined with Nakamoto Holdings in 2025; the resulting company trades on Nasdaq under the symbol NAKA.